| Record Information |
| Version |
3.5 |
| Creation Date |
2006-05-22 08:17:31 -0600 |
| Update Date |
2013-02-08 17:11:10 -0700 |
| HMDB ID |
HMDB01993 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
7a-Hydroxy-cholestene-3-one |
| Description |
7a-Hydroxy-cholestene-3-one is a metabolite in bile acid synthesis. It is derived from 7a-hydroxy-cholesterol and can be further metabolized to 7a,12a,-dihydroxy-cholest-4-en-3-one. Analysis of 7a-Hydroxycholestene-3-one (HCO) in serum may serve as a novel, simple, and sensitive method for the detection of bile acid malabsorption in patients with chronic diarrhea of unknown origin (PMID 9952217 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 7 alpha-3ox-C
- 7 alpha-Hydroxy-4-cholesten-3-one
- 7-a-Hydroxy-4-cholesten-3-one
- 7-a-Hydroxycholest-4-en-3-one
- 7-alpha-Hydroxy-4-cholesten-3-one
- 7-alpha-Hydroxycholest-4-en-3-one
- 7-Hydroxycholest-4-en-3-one
- 7a-Hydroxy-4-cholesten-3-one-12alpha
- 7alpha-Hydroxy-4-cholesten-3-one
- 7alpha-Hydroxycholest-4-en-3-one
- Cholest-4-en-7alpha-ol-3-one
- HCO
|
| Chemical Formula |
C27H44O2 |
| Average Molecular Weight |
400.6371 |
| Monoisotopic Molecular Weight |
400.334130652 |
| IUPAC Name |
(1S,2R,9R,10S,11S,14R,15R)-9-hydroxy-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
| Traditional IUPAC Name |
cholest-4-en-7α-ol-3-one |
| CAS Registry Number |
3862-25-7 |
| SMILES |
[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)CC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C |
| InChI Identifier |
InChI=1S/C27H44O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h15,17-18,21-25,29H,6-14,16H2,1-5H3/t18-,21-,22+,23+,24-,25+,26+,27-/m1/s1 |
| InChI Key |
IOIZWEJGGCZDOL-RQDYSCIWSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Lipids |
| Class |
Steroids and Steroid Derivatives |
| Sub Class |
Cholesterols and Derivatives |
| Other Descriptors |
- 3-oxo steroid(ChEBI)
- 7alpha-hydroxy steroid(ChEBI)
- Aliphatic Homopolycyclic Compounds
- C27 bile acids, alcohols, and derivatives(Lipidmaps)
- Cholesterol and derivatives(KEGG)
- cholestanoid(ChEBI)
|
| Substituents |
- 3 Keto Steroid
- 7 Hydroxy Steroid
- Cyclic Alcohol
- Cyclohexane
- Cyclohexene
- Decaline
- Ketone
- Secondary Alcohol
- Sesterterpene
|
| Direct Parent |
Cholesterols and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Cell signaling
- Fuel and energy storage
- Fuel or energy source
- Hormones, Membrane component
- Membrane integrity/stability
|
| Application |
- Nutrients
- Stabilizers
- Surfactants and Emulsifiers
|
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Urine |
Detected and Quantified |
|
109.8 +/- 16.44 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.18 (0.102-0.28) uM |
Adult (>18 years old) |
Both |
Irritable bowel syndrome |
Not Available |
| Blood |
Detected and Quantified |
|
0.13 (0.09-0.17) uM |
Adult (>18 years old) |
Both |
Diverticular disease |
Not Available |
| Blood |
Detected and Quantified |
|
0.15 uM |
Adult (>18 years old) |
Both |
Ileocysoiplasty |
Not Available |
| Blood |
Detected and Quantified |
|
0.132 uM |
Adult (>18 years old) |
Both |
Meckels diverticulum |
Not Available |
| Blood |
Detected and Quantified |
|
0.127 uM |
Adult (>18 years old) |
Both |
Atrophic gastritis |
Not Available |
| Blood |
Detected and Quantified |
|
0.12 uM |
Adult (>18 years old) |
Both |
Cronh's ileitis |
Not Available |
| Blood |
Detected and Quantified |
|
0.0999 uM |
Adult (>18 years old) |
Both |
Chronic pancreatitis |
Not Available |
| Blood |
Detected and Quantified |
|
0.16 (0.09-0.25) uM |
Adult (>18 years old) |
Both |
Alcohol abuse |
Not Available |
| Blood |
Detected and Quantified |
|
0.033 +/- 0.011 uM |
Adult (>18 years old) |
Both |
Gallstone disease |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Gallbladder disease |
- Hillebrant CG, Axelson M, Bjorkhem I, Wang FH, Nyberg B, Einarsson C: Effects of short-term treatment with pravastatin on the hepatic synthesis of cholesterol and bile acids in gallstone patients. Eur J Clin Invest. 1998 Apr;28(4):324-8.
Pubmed: 9615912
|
| Irritable bowel syndrome |
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|
| Diverticular disease |
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|
| Ileocystoplasty |
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|
| Meckels diverticulum |
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|
| Atrophic gastritis |
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|
| Crohn's disease |
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|
| Chronic pancreatitis |
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|
| Alcoholism |
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022786 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
110306  |
| KEGG Compound ID |
C05455  |
| BioCyc ID |
Not Available |
| BiGG ID |
45848  |
| Wikipedia Link |
HCO  |
| NuGOwiki Link |
HMDB01993  |
| Metagene Link |
HMDB01993  |
| METLIN ID |
6419  |
| PubChem Compound |
123743  |
| PDB ID |
Not Available |
| ChEBI ID |
17899  |
| References |
| Synthesis Reference |
Alexander, David L.; Fisher, Jed F. A convenient synthesis of 7a-hydroxycholest-4-en-3-one by the hydroxypropyl-b-cyclodextrin-facilitated cholesterol oxidase oxidation of 3b,7a-cholest-5-ene-3,7-diol. Steroids (1995), 60(3), 290-4. |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Lin RC, Fillenwarth MJ, Du X: Cytotoxic effect of 7alpha-hydroxy-4-cholesten-3-one on HepG2 cells: hypothetical role of acetaldehyde-modified delta4-3-ketosteroid-5beta-reductase (the 37-kd-liver protein) in the pathogenesis of alcoholic liver injury in the rat. Hepatology. 1998 Jan;27(1):100-7.
Pubmed: 9425924
- Skrede S, Bjorkhem I, Buchmann MS, Hopen G, Fausa O: A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. J Clin Invest. 1985 Feb;75(2):448-55.
Pubmed: 3919058
- Axelson M, Bjorkhem I, Reihner E, Einarsson K: The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man. FEBS Lett. 1991 Jun 24;284(2):216-8.
Pubmed: 2060639
- Skrede S, Bjorkhem I: A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis. Scand J Clin Lab Invest Suppl. 1985;177:15-21.
Pubmed: 3865344
- Skrede S, Buchmann MS, Bjorkhem I: Hepatic 7 alpha-dehydroxylation of bile acid intermediates, and its significance for the pathogenesis of cerebrotendinous xanthomatosis. J Lipid Res. 1988 Feb;29(2):157-64.
Pubmed: 3367085
- Sauter GH, Munzing W, von Ritter C, Paumgartner G: Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci. 1999 Jan;44(1):14-9.
Pubmed: 9952217
- Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.
Pubmed: 8723414
|